FibroGen Appoints Michael Kauffman, M.D., Ph.D. to its Board of Directors
Provided By GlobeNewswire
Last update: Jun 9, 2025
SAN FRANCISCO, June 09, 2025 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) today announced the appointment of Dr. Michael Kauffman to its Board of Directors effective June 4, 2025.
Read more at globenewswire.comNASDAQ:FGEN (9/3/2025, 7:15:58 PM)
11.96
-0.22 (-1.81%)
Find more stocks in the Stock Screener
